Scolaris Content Display Scolaris Content Display

Anticonvulsants for cocaine dependence

This is not the most recent version

view the current version 17 April 2015

References

Additional references

Amato 2007

Amato L, Minozzi S, Pani PP, Davoli M. Antipsychotic medication for cocaine dependence. Cochrane Database of Systematic Reviews 2007, Issue 3.

Campbell 1999

Campbell UC, Lac ST, Carroll ME. Effects of baclofen on maintenance and reinstatement of intravenous cocaine self‐administration in rats. Psychopharmacology 1999;143(2):209‐14.

Chalmers 1993

Chalmers I. The Cochrane collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care. Annals of the New York Academy of Sciences 1993;703:156‐63; discussion 163‐5.

Craddok 1997

Craddok SG, Rounds‐Bryant JL, Flinn PM, Hubbard RL. Characteristics and pre‐treatment behaviours of clients entering drug abuse treatment: 1969 to 1993. American Journal of Drug and Alcohol Abuse 1997;23(1):43‐59.

Crosby 1991

Crosby RD, Halikas JA, Carlson G. Pharmacotherapeutic interventions for cocaine abuse: present practices and future directions. Journal of Addictive Diseases 1991;10(4):13‐30.

Czapinski 2005

Czapinski P, Blaszczyk B, Czuczwar SJ. Mechanisms of action of antiepileptic drugs.. Curr Top Med Chem 2005;5(1):3‐14.

Davoli in press

Davoli M, Pasqualini F, Belleudi V, Bargagli AM, Perucci CA. Changing pattern of drug abuse among patients entering treatment in Lazio, Italy, 1996‐2003: transition from heroin to cocaine use. European Addiction Research..

Di Chiara 1988

Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 1988;85(14):5274‐8.

Drevets 1999

Drevets WC, Price JC, Kupfer DJ, Kinahan PE, Lopresti B, Holt D, et al. PET Measures of Amphetamine‐Induced Dopamine Release in Ventral versus Dorsal Striatum. Neuropsychopharmacology 1999;21(6):694‐709.

Drevets 2001

Drevets WC, Gautier C, Price JC, Kupfer DJ, Kinahan PE, Grace AA, et al. Amphetamine‐Induced Dopamine Release in Human Ventral Striatum Correlates with Euphoria. Biol Psychiatry 2001;49(2):81‐96.

DSM‐IV‐R

American Psychiatric Association (Pb). Diagnostic and Statistical Manual of Mental Disorders. 4 edition. Washington DC: American Psychiatric Association, 1994.

EMCDDA 2006

The state of the drugs problem in the European Union and Norway. European Monitoring Centre for Drug and Drug Abuse, Luxemburg2006.

Faggiano 2003

Faggiano F, Vigna‐Taglianti F, Versino E, Lemma P. Methadone maintenance at different dosages for opioid dependence. Cochrane Database of Systematic Reviews 2003, Issue 3.

Grabowski 1997

Grabowski J, Roache JD, Scmitz JM, Rhoades H, Creson D, Korszun A. Replacement medication for cocaine dependence. Journal of Clinical Psychopharmacology 1997;17(6):485‐8.

Higgins 1994

Higgins ST, Budney AJ, Bickel WK, Foerg FE, Donham R, Badjer GJ. Incentives Improve Outcome in Outpatient Behavioral Treatment of Cocaine Dependence. Archives of General Psychiatry 1994;51(7):568‐76.

Higgins 2007

Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. The Cochrane Library2007, issue 2.

Karch 2006

Karch SB. A Brief History of Cocaine. 2nd Edition. New York, NY: CRC Press, 2006.

Knapp 2007

Knapp WP, Soares BGO, Farrel M, Lima MS. Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. Cochrane Database of Systematic Reviews 2007, Issue 3.

Koob 1997

Koob GF, Nestler EJ. The neurobiology of drug addiction. Journal of Neuropsychiatry and Clinical Neurosciences 1997;9(3):482‐97.

Kosten 1996

Kosten T, McCance E. A review of pharmacotherapies for substance abuse. American Journal of Addiction 1996;5(1):58‐65.

Kranzler 1995

Kranzler HR, Bauer LO, Hersh D, Klinghoffer V. Carbamazepine treatment of cocaine dependence: a placebo‐controlled trial.. Drug and Alcohol Dependence 1995;38(3):203‐11.

Kushner 1999

Kushner SA, Dewey SL, Kornetsky C. The irreversible gamma‐aminobutyric acid (GABA) trnsaminase inhibitor gamma‐vinyl‐GABA blocks cocaine self‐administration in rats. Journal of Pharmacology and Experimental Therapeutics 1999;290(2):792‐802.

Landmark 2007

Landmark CJ. Targets for antiepileptic drugs in the synapse.. Med Sci Monit. 2007 Jan;13(1) 2007;13(1):RA1‐7.

Lima 2003

Lima MS, Reisser AAP, Soares BGO, Farrell M. Antidepressants for cocaine dependence. Cochrane Database of Systematic Reviews 2003, Issue 2.

Lima Reisser 2000

Lima Reisser A, Lima MS, Soares BGO, Farrell M. Carbamazepine for cocaine dependence. Cochrane Database of Systematic Reviews 2000, Issue 2.

Mattick 2003

Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2003, Issue 2.

Moher 1998

Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analyses?. Lancet 1998;352(9128):609‐13.

Moher 1999

Moher D, Cook DJ, Eastwood S, Olkin I, Drummond R, Stroup DF for the Quorum Group. Improving the quality of reports of metaanalyses of randomised controlled trials: the QUORUM statement. Lancet 1999;354(9193):1896‐900.

NSDUH 2005

Substance Abuse and Mental Health Services Administration (2005). Overview of Findings from the 2004 National Survey on Drug Use and Health (Office of Applied Studies, NSDUH Series H‐27, DHHS Publication No. SMA 05‐4061). Rockville, MD.

Ntais 2005

Ntais C, Pakos E, Panayiotis K, Ioannidis JPA. Benzodiazepines for alcohol withdrawal. Cochrane Database of Systematic Reviews 2005, Issue 3.

O'Brian 2001

O'Brian C. Drug addiction and drug abuse. In: Hardman JG, Lee CL editor(s). The pharmacological basis of Therapeutics. New York: MCGraw‐Hill, 2001:621‐42.

Policarpou 2005

Polycarpou A, Papanikolaou P, Contopoulos‐Ioannidis DG, Ioannidis JPA. Anticonvulsants for the management of alcohol withdrawal. Cochrane Database of Systematic Reviews 2005, Issue 3.

Schulz 1995

Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408‐12.

Siliquini 2005

Siliquini R, Morra A, Versino E, Renga G. Recreational drug consumers: who seek treatment? European. Journal of Public Health 2005;15(6):580‐6.

Soares 2003

Soares BGO, Lima MS, Reisser AAP, Farrell M. Dopamine agonists for cocaine dependence. Cochrane Database of Systematic Reviews 2003, Issue 2.

Sorensen 1991

Sorensen JL, Wermuth LA, Gibson DR, Choi K, Guydish JR. Preventing AIDS in drug abusers and their sexual partners. New York: Guilford, 1991.

Suelves 2001

Suelves JM, Brugal MT, Cayla JA, Torralba L. Change in health‐related problems of cocaine consumption in Catalonia, Spain.. Med Clin (Barc) 2001;117(15):581‐3.

Topp 2003

Topp L, Day C, Degenhardt L. Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. Drug & Alcohol Dependence 2003;70(3):275‐86.

Volkow 2003

Volkow ND, Fowler JS, Wang GJ. The addicted human brain: Insights for imaging studies. Journal of Clinical Investigation 2003;111(10):1444‐51.